{"transactions":[{"id":795411,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2026-05-01T20:20:49.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The options were granted pursuant to the Company's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following May 1, 2026, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":2.82,"expiration_date":"2036-05-01","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001555132-26-000008","document":"form4-05012026_080545.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000155513226000008/form4-05012026_080545.xml","form_type":"4"}},{"id":943029,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":false,"shares":3281,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on January 1, 2025, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":5805,"derivative":{"exercise_price":10.42,"expiration_date":"2034-12-08","underlying":"Common Stock","underlying_shares":3281},"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":943028,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":false,"shares":2895,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":316,"derivative":{"exercise_price":10.42,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":2895},"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":943027,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":false,"shares":20744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on February 2, 2024."}],"balance_after":0,"derivative":{"exercise_price":10.42,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":20744},"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":943026,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":false,"shares":2493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested or vests as to 1/36th of the total award monthly, with the first tranche vested on April 1, 2023, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":3211,"derivative":{"exercise_price":10.42,"expiration_date":"2033-03-08","underlying":"Common Stock","underlying_shares":2493},"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":943025,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-07","kind":"sale","planned":false,"acquired":false,"shares":26920,"price":39.1079,"value":1052784.668,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.04 to $39.85 per share, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":943024,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":true,"shares":3281,"price":10.42,"value":34188.02,"ownership":{"direct":true},"balance_after":26920,"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":943023,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":true,"shares":2895,"price":10.42,"value":30165.9,"ownership":{"direct":true},"balance_after":23639,"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":943022,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-07","kind":"exercise","planned":false,"acquired":true,"shares":20744,"price":10.42,"value":216152.48,"ownership":{"direct":true},"balance_after":20744,"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":943021,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-06","kind":"sale","planned":false,"acquired":false,"shares":2493,"price":38.616,"value":96269.688,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.61 to $38.6225 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 2 of this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":943020,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-08T21:30:38.000Z","date":"2026-01-06","kind":"exercise","planned":false,"acquired":true,"shares":2493,"price":10.42,"value":25977.06,"ownership":{"direct":true},"balance_after":2493,"source":{"system":"sec-edgar","filing":"0001555132-26-000006","document":"form4-01082026_090134.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513226000006/form4-01082026_090134.xml","form_type":"4"}},{"id":950819,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2026-01-05T21:05:39.000Z","date":"2026-01-05","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":4.2351,"value":2117.55,"ownership":{"direct":true},"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001555132-26-000002","document":"form4-01052026_040104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000155513226000002/form4-01052026_040104.xml","form_type":"4"}},{"id":1031149,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2025-09-29T20:21:00.000Z","date":"2025-09-25","kind":"grant","planned":false,"acquired":true,"shares":48800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 25, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":48800,"derivative":{"exercise_price":3.92,"expiration_date":"2035-09-25","underlying":"Common Stock, par value $0.0001","underlying_shares":48800},"source":{"system":"sec-edgar","filing":"0001104659-25-094503","document":"tm2527377-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925094503/tm2527377-9_4seq1.xml","form_type":"4"}},{"id":1032848,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-24T20:19:29.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/9 of the total award monthly with the first tranche vesting on October 1, 2025, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":18000,"derivative":{"exercise_price":23.67,"expiration_date":"2035-09-21","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001555132-25-000005","document":"form4-09242025_080925.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000155513225000005/form4-09242025_080925.xml","form_type":"4"}},{"id":1199402,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001","published_at":"2025-03-18T20:15:22.000Z","date":"2025-03-17","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":5.7845,"value":5784.5,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001104659-25-025032","document":"tm259651-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925025032/tm259651-1_4seq1.xml","form_type":"4"}},{"id":1278585,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2025-02-07T21:05:14.000Z","date":"2025-02-06","kind":"grant","planned":false,"acquired":true,"shares":18600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest as follows: (i) 50% on July 15, 2025, (ii) 25% on September 30, 2025 and 25% on December 31, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":18600,"derivative":{"exercise_price":6.91,"expiration_date":"2035-02-06","underlying":"Common Stock, par value $0.0001","underlying_shares":18600},"source":{"system":"sec-edgar","filing":"0001104659-25-010528","document":"tm255923-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465925010528/tm255923-1_4seq1.xml","form_type":"4"}},{"id":1397826,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2024-09-30T22:33:18.000Z","date":"2024-09-26","kind":"grant","planned":false,"acquired":true,"shares":34900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 26, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":34900,"derivative":{"exercise_price":6.81,"expiration_date":"2034-09-26","underlying":"Common Stock, par value $0.0001","underlying_shares":34900},"source":{"system":"sec-edgar","filing":"0001104659-24-104437","document":"tm2425266-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465924104437/tm2425266-1_4seq1.xml","form_type":"4"}},{"id":1771442,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2023-09-29T21:01:08.000Z","date":"2023-09-28","kind":"grant","planned":false,"acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following September 28, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":26100,"derivative":{"exercise_price":2.5,"expiration_date":"2033-09-28","underlying":"Common Stock, par value $0.0001","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001104659-23-105395","document":"tm2327241-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923105395/tm2327241-5_4seq1.xml","form_type":"4"}},{"id":1807126,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T22:02:51.000Z","date":"2023-08-14","kind":"sale","planned":false,"acquired":false,"shares":1241,"price":138.1585,"value":171454.6985,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $137.78 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":14868,"source":{"system":"sec-edgar","filing":"0001765581-23-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000092/edgardoc.xml","form_type":"4"}},{"id":1807125,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-15T22:02:51.000Z","date":"2023-08-11","kind":"grant","planned":false,"acquired":true,"shares":3075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024."}],"balance_after":16109,"source":{"system":"sec-edgar","filing":"0001765581-23-000092","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558123000092/edgardoc.xml","form_type":"4"}},{"id":1937820,"issuer":{"id":5349,"kind":"organization","name":"Altimmune, Inc.","symbol":"ALT"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (option to buy)","published_at":"2023-03-27T20:17:02.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option become vested and exercisable in 36 substantially equal monthly installments following March 23, 2023, subject to the reporting person's continued service through the applicable vesting"}],"balance_after":47000,"derivative":{"exercise_price":4.19,"expiration_date":"2033-03-23","underlying":"Common Stock, par value $0.0001","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001104659-23-037128","document":"tm2310588-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326190/000110465923037128/tm2310588-4_4seq1.xml","form_type":"4"}},{"id":2190638,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:44:38.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":1089,"price":152.3229,"value":165879.6381,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":13034,"source":{"system":"sec-edgar","filing":"0001765581-22-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000100/edgardoc.xml","form_type":"4"}},{"id":2190637,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-08-09T22:44:38.000Z","date":"2022-08-05","kind":"grant","acquired":true,"shares":2561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 28, 2023."}],"balance_after":14123,"source":{"system":"sec-edgar","filing":"0001765581-22-000100","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558122000100/edgardoc.xml","form_type":"4"}},{"id":2240743,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-06-07T21:16:35.000Z","date":"2022-06-04","kind":"exercise","acquired":false,"shares":7059,"price":9.5,"value":67060.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted on June 4, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on June 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on June 4, 2022."}],"balance_after":0,"derivative":{"exercise_date":"2022-06-04","expiration_date":"2022-06-04","underlying":"Common Stock","underlying_shares":7059},"source":{"system":"sec-edgar","filing":"0001628280-22-016485","document":"wf-form4_165463657846481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828022016485/wf-form4_165463657846481.xml","form_type":"4"}},{"id":2240742,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-07T21:16:35.000Z","date":"2022-06-04","kind":"grant","acquired":true,"shares":7059,"price":9.5,"value":67060.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":54069,"source":{"system":"sec-edgar","filing":"0001628280-22-016485","document":"wf-form4_165463657846481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828022016485/wf-form4_165463657846481.xml","form_type":"4"}},{"id":2248147,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-06-02T16:46:11.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":9474,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":9474,"derivative":{"exercise_date":"2023-05-31","underlying":"Common Stock","underlying_shares":9474},"source":{"system":"sec-edgar","filing":"0001628280-22-016009","document":"wf-form4_165418835785568.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828022016009/wf-form4_165418835785568.xml","form_type":"4"}},{"id":2259520,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T20:56:53.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting."}],"balance_after":20000,"derivative":{"exercise_price":1.7,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-063913","document":"tm2216627-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000110465922063913/tm2216627-8_4seq1.xml","form_type":"4"}},{"id":2272112,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-13T16:26:35.000Z","date":"2022-05-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service."}],"balance_after":25000,"derivative":{"exercise_price":1.24,"expiration_date":"2032-05-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-22-003004","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000117911022003004/edgar.xml","form_type":"4"}},{"id":2608307,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-10T21:40:30.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":1306,"price":147.96,"value":193235.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":11562,"source":{"system":"sec-edgar","filing":"0001765581-21-000110","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000110/edgardoc.xml","form_type":"4"}},{"id":2619825,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2021-08-02T22:28:41.000Z","date":"2021-07-29","kind":"grant","acquired":true,"shares":2246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 29, 2022."}],"balance_after":12868,"source":{"system":"sec-edgar","filing":"0001765581-21-000085","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558121000085/edgardoc.xml","form_type":"4"}},{"id":2678162,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-09T00:04:46.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":7059,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":7059,"derivative":{"exercise_date":"2022-06-04","underlying":"Common Stock","underlying_shares":7059},"source":{"system":"sec-edgar","filing":"0001593968-21-001573","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001573/primary_01.xml","form_type":"4"}},{"id":2684426,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-04T00:03:26.000Z","date":"2021-06-01","kind":"exercise","acquired":false,"shares":8303,"price":11.64,"value":96646.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted on June 1, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on June 1, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on June 1, 2021."}],"balance_after":0,"derivative":{"exercise_date":"2021-06-01","expiration_date":"2021-06-01","underlying":"Common Stock","underlying_shares":8303},"source":{"system":"sec-edgar","filing":"0001593968-21-001522","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001522/primary_01.xml","form_type":"4"}},{"id":2684425,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T00:03:26.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":8303,"price":11.64,"value":96646.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":47010,"source":{"system":"sec-edgar","filing":"0001593968-21-001522","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396821001522/primary_01.xml","form_type":"4"}},{"id":2698259,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-24T21:19:20.000Z","date":"2021-05-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting."}],"balance_after":20000,"derivative":{"exercise_price":3.24,"expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-071353","document":"tm2116997-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000110465921071353/tm2116997-8_4seq1.xml","form_type":"4"}},{"id":2714577,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-13T20:35:09.000Z","date":"2021-05-12","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service."}],"balance_after":25000,"derivative":{"exercise_price":23.25,"expiration_date":"2031-05-11","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-21-005315","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000117911021005315/edgar.xml","form_type":"4"}},{"id":2989534,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-11-06T21:42:04.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This non-qualified stock option was granted on August 8, 2013. The ordinary shares subject to this option award vested over 1 year in 12 equal monthly installments and were fully vested as of September 1, 2014."}],"balance_after":0,"derivative":{"exercise_price":81.76,"expiration_date":"2023-08-07","underlying":"Ordinary Shares","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001765581-20-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000109/edgardoc.xml","form_type":"4"}},{"id":2989533,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-11-06T21:42:04.000Z","date":"2020-11-04","kind":"exercise","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This non-qualified stock option was granted on August 9, 2012. The ordinary shares subject to this option award vested over 1 year in 12 equal monthly installments and were fully vested as of August 9, 2013."}],"balance_after":0,"derivative":{"exercise_price":46.83,"expiration_date":"2022-08-08","underlying":"Ordinary Shares","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001765581-20-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000109/edgardoc.xml","form_type":"4"}},{"id":2989532,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-11-06T21:42:04.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":8000,"price":152,"value":1216000.0,"ownership":{"direct":true},"balance_after":10622,"source":{"system":"sec-edgar","filing":"0001765581-20-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000109/edgardoc.xml","form_type":"4"}},{"id":2989531,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-11-06T21:42:04.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":8000,"price":46.83,"value":374640.0,"ownership":{"direct":true},"balance_after":18622,"source":{"system":"sec-edgar","filing":"0001765581-20-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000109/edgardoc.xml","form_type":"4"}},{"id":2989530,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-11-06T21:42:04.000Z","date":"2020-11-04","kind":"sale","acquired":false,"shares":4500,"price":156,"value":702000.0,"ownership":{"direct":true},"balance_after":10622,"source":{"system":"sec-edgar","filing":"0001765581-20-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000109/edgardoc.xml","form_type":"4"}},{"id":2989529,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-11-06T21:42:04.000Z","date":"2020-11-04","kind":"exercise","acquired":true,"shares":4500,"price":81.76,"value":367920.0,"ownership":{"direct":true},"balance_after":15122,"source":{"system":"sec-edgar","filing":"0001765581-20-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000109/edgardoc.xml","form_type":"4"}},{"id":3004455,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-10-19T20:14:54.000Z","date":"2020-10-15","kind":"exercise","acquired":false,"shares":2200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted on October 15, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on October 15, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on October 15, 2020."}],"balance_after":0,"derivative":{"exercise_date":"2020-10-15","expiration_date":"2020-10-15","underlying":"Common Stock","underlying_shares":2200},"source":{"system":"sec-edgar","filing":"0001593968-20-002068","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396820002068/primary_01.xml","form_type":"4"}},{"id":3004454,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-19T20:14:54.000Z","date":"2020-10-15","kind":"grant","acquired":true,"shares":2200,"price":10.36,"value":22792.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":38707,"source":{"system":"sec-edgar","filing":"0001593968-20-002068","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000159396820002068/primary_01.xml","form_type":"4"}},{"id":3063271,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-08-10T20:54:10.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":6765,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in full on July 30, 2021."}],"balance_after":6765,"derivative":{"exercise_price":127.07,"expiration_date":"2030-08-05","underlying":"Ordinary Shares","underlying_shares":6765},"source":{"system":"sec-edgar","filing":"0001765581-20-000083","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000083/edgardoc.xml","form_type":"4"}},{"id":3063270,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-08-10T20:54:10.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":931,"price":125.8708,"value":117185.7148,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":10622,"source":{"system":"sec-edgar","filing":"0001765581-20-000083","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000083/edgardoc.xml","form_type":"4"}},{"id":3063269,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2020-08-10T20:54:10.000Z","date":"2020-08-06","kind":"grant","acquired":true,"shares":2705,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 30, 2021."}],"balance_after":11553,"source":{"system":"sec-edgar","filing":"0001765581-20-000083","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558120000083/edgardoc.xml","form_type":"4"}},{"id":3127774,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Right to Buy Restricted Stock Unit (RSU)","published_at":"2020-06-02T22:21:43.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":8303,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":8303,"derivative":{"exercise_date":"2021-06-01","underlying":"Common Stock","underlying_shares":8303},"source":{"system":"sec-edgar","filing":"0001628280-20-008846","document":"wf-form4_159113648552749.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828020008846/wf-form4_159113648552749.xml","form_type":"4"}},{"id":3131164,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2020-05-29T19:52:55.000Z","date":"2020-05-28","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted on May 28, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 28, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on May 28, 2020."}],"balance_after":0,"derivative":{"exercise_date":"2020-05-28","expiration_date":"2020-05-28","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-20-008626","document":"wf-form4_159078195594533.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828020008626/wf-form4_159078195594533.xml","form_type":"4"}},{"id":3131163,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T19:52:55.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":6000,"price":10.99,"value":65940.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":36507,"source":{"system":"sec-edgar","filing":"0001628280-20-008626","document":"wf-form4_159078195594533.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828020008626/wf-form4_159078195594533.xml","form_type":"4"}},{"id":3135272,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-26T19:24:51.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service."}],"balance_after":25000,"derivative":{"exercise_price":6.22,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-006604","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000117911020006604/edgar.xml","form_type":"4"}},{"id":3136607,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-22T21:18:22.000Z","date":"2020-05-20","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become fully exercisable on the earlier of the first anniversary following the date of grant or the next scheduled Annual Meeting."}],"balance_after":11000,"derivative":{"exercise_price":4.2,"expiration_date":"2030-05-19","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001104659-20-065473","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000110465920065473/a4.xml","form_type":"4"}},{"id":3306114,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T21:38:10.000Z","date":"2020-01-17","kind":"purchase","acquired":true,"shares":1000,"price":4.87,"value":4870.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001633070-20-000002","document":"wf-form4_157964267039151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000163307020000002/wf-form4_157964267039151.xml","form_type":"4"}},{"id":3392398,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Right to Buy Restricted Stock Unit (RSU)","published_at":"2019-10-17T19:16:35.000Z","date":"2019-10-15","kind":"grant","acquired":true,"shares":2200,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":2200,"derivative":{"exercise_date":"2020-10-15","underlying":"Common Stock","underlying_shares":2200},"source":{"system":"sec-edgar","filing":"0001628280-19-012373","document":"wf-form4_157133976524642.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019012373/wf-form4_157133976524642.xml","form_type":"4"}},{"id":3396850,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-07T21:29:28.000Z","date":"2019-10-04","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.01,"exercise_date":"2015-12-13","expiration_date":"2019-11-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001628280-19-012187","document":"wf-form4_157048374467434.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019012187/wf-form4_157048374467434.xml","form_type":"4"}},{"id":3396849,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-07T21:29:28.000Z","date":"2019-10-04","kind":"tax_withholding","acquired":false,"shares":8824,"price":10.21,"value":90093.04,"ownership":{"direct":true},"balance_after":30507,"source":{"system":"sec-edgar","filing":"0001628280-19-012187","document":"wf-form4_157048374467434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019012187/wf-form4_157048374467434.xml","form_type":"4"}},{"id":3396848,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-07T21:29:28.000Z","date":"2019-10-04","kind":"exercise","acquired":true,"shares":10000,"price":9.01,"value":90100.0,"ownership":{"direct":true},"balance_after":39331,"source":{"system":"sec-edgar","filing":"0001628280-19-012187","document":"wf-form4_157048374467434.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019012187/wf-form4_157048374467434.xml","form_type":"4"}},{"id":3429887,"issuer":{"id":116059,"kind":"organization","name":"Axcella Health Inc.","symbol":"AXLA"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-08-23T20:34:48.000Z","date":"2019-08-21","kind":"grant","acquired":true,"shares":22000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in equal 1/12th quarterly installments during the twelve quarters following the grant date and become fully exercisable on the third anniversary of the grant date."}],"balance_after":22000,"derivative":{"exercise_price":8.11,"expiration_date":"2029-08-21","underlying":"Common Stock","underlying_shares":22000},"source":{"system":"sec-edgar","filing":"0001104659-19-047155","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1555132/000110465919047155/a4.xml","form_type":"4"}},{"id":3440877,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-08-12T21:38:35.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":4805,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2019."}],"balance_after":4805,"derivative":{"exercise_price":137.12,"expiration_date":"2029-08-07","underlying":"Common Stock","underlying_shares":4805},"source":{"system":"sec-edgar","filing":"0001765581-19-000078","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000078/edgardoc.xml","form_type":"4"}},{"id":3440876,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-08-12T21:38:35.000Z","date":"2019-08-09","kind":"sale","acquired":false,"shares":726,"price":135.6503,"value":98482.1178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $135.65 to $135.7054. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected."}],"balance_after":8848,"source":{"system":"sec-edgar","filing":"0001765581-19-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000078/edgardoc.xml","form_type":"4"}},{"id":3440875,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2019-08-12T21:38:35.000Z","date":"2019-08-08","kind":"grant","acquired":true,"shares":1920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 1, 2020."}],"balance_after":9574,"source":{"system":"sec-edgar","filing":"0001765581-19-000078","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000176558119000078/edgardoc.xml","form_type":"4"}},{"id":3507945,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Right to Buy Restricted Stock Units (RSU)","published_at":"2019-05-31T00:39:35.000Z","date":"2019-05-28","kind":"grant","acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":6000,"derivative":{"exercise_date":"2020-05-28","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-19-007414","document":"wf-form4_155926316005918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019007414/wf-form4_155926316005918.xml","form_type":"4"}},{"id":3507944,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-05-31T00:39:35.000Z","date":"2019-05-30","kind":"exercise","acquired":false,"shares":4240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted on May 30, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 30, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on May 30, 2019."}],"balance_after":0,"derivative":{"exercise_date":"2019-05-30","expiration_date":"2019-05-30","underlying":"Common Stock","underlying_shares":4240},"source":{"system":"sec-edgar","filing":"0001628280-19-007414","document":"wf-form4_155926316005918.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019007414/wf-form4_155926316005918.xml","form_type":"4"}},{"id":3507943,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-31T00:39:35.000Z","date":"2019-05-30","kind":"exercise","acquired":true,"shares":4240,"price":9.91,"value":42018.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":29331,"source":{"system":"sec-edgar","filing":"0001628280-19-007414","document":"wf-form4_155926316005918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000162828019007414/wf-form4_155926316005918.xml","form_type":"4"}},{"id":3510382,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T19:59:18.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service."}],"balance_after":25000,"derivative":{"exercise_price":16.27,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-19-032122","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919032122/a4.xml","form_type":"4"}},{"id":3697619,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-01-11T20:44:45.000Z","date":"2019-01-10","kind":"purchase","acquired":true,"shares":1000,"price":11.23,"value":11230.0,"ownership":{"direct":true},"balance_after":25091,"source":{"system":"sec-edgar","filing":"0001437749-19-000726","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000143774919000726/rdgdoc.xml","form_type":"4"}},{"id":3846018,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-08-13T22:20:19.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":3735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2018."}],"balance_after":3735,"derivative":{"exercise_price":177.73,"expiration_date":"2028-08-08","underlying":"Ordinary Shares","underlying_shares":3735},"source":{"system":"sec-edgar","filing":"0001232524-18-000140","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000140/edgardoc.xml","form_type":"4"}},{"id":3846017,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T22:20:19.000Z","date":"2018-08-10","kind":"sale","acquired":false,"shares":660,"price":176.6108,"value":116563.128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.61 to $177.1295, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":7654,"source":{"system":"sec-edgar","filing":"0001232524-18-000140","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000140/edgardoc.xml","form_type":"4"}},{"id":3846016,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2018-08-13T22:20:19.000Z","date":"2018-08-09","kind":"grant","acquired":true,"shares":1495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 2, 2019."}],"balance_after":8314,"source":{"system":"sec-edgar","filing":"0001232524-18-000140","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252418000140/edgardoc.xml","form_type":"4"}},{"id":3862920,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-23T16:34:18.000Z","date":"2018-07-20","kind":"purchase","acquired":true,"shares":2500,"price":23,"value":57500.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001104659-18-046532","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465918046532/a4.xml","form_type":"4"}},{"id":3865400,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-18T16:33:31.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in equal quarterly installments during the twelve quarters following the grant date."}],"balance_after":25000,"derivative":{"exercise_price":23,"expiration_date":"2028-07-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-18-045774","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465918045774/a4.xml","form_type":"4"}},{"id":3911345,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true}}],"security":"Right to Buy Restricted Stock Unit (RSU)","published_at":"2018-06-01T21:35:43.000Z","date":"2018-05-30","kind":"exercise","acquired":true,"shares":4240,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":4240,"derivative":{"exercise_date":"2019-05-30","underlying":"Common Stock","underlying_shares":4240},"source":{"system":"sec-edgar","filing":"0001437749-18-011098","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000143774918011098/rdgdoc.xml","form_type":"4"}},{"id":3917634,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2018-05-25T21:38:06.000Z","date":"2018-05-23","kind":"exercise","acquired":false,"shares":4286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted on June 1, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 23, 2018."}],"balance_after":0,"derivative":{"exercise_date":"2018-05-23","expiration_date":"2018-05-23","underlying":"Common Stock","underlying_shares":4286},"source":{"system":"sec-edgar","filing":"0001437749-18-010771","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000143774918010771/rdgdoc.xml","form_type":"4"}},{"id":3917633,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-25T21:38:06.000Z","date":"2018-05-23","kind":"exercise","acquired":true,"shares":4286,"price":13.65,"value":58503.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":24091,"source":{"system":"sec-edgar","filing":"0001437749-18-010771","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000143774918010771/rdgdoc.xml","form_type":"4"}},{"id":4235136,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-08-14T21:33:06.000Z","date":"2017-08-10","kind":"grant","acquired":true,"shares":3415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan.  Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest in 12 equal monthly installments beginning on September 1, 2017."}],"balance_after":3415,"derivative":{"exercise_price":143.66,"expiration_date":"2027-08-09","underlying":"Ordinary Shares","underlying_shares":3415},"source":{"system":"sec-edgar","filing":"0001232524-17-000152","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000152/edgardoc.xml","form_type":"4"}},{"id":4235135,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-08-14T21:33:06.000Z","date":"2017-08-11","kind":"sale","acquired":false,"shares":3,"price":144.217,"value":432.651,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6819,"source":{"system":"sec-edgar","filing":"0001232524-17-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000152/edgardoc.xml","form_type":"4"}},{"id":4235134,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-08-14T21:33:06.000Z","date":"2017-08-11","kind":"sale","acquired":false,"shares":659,"price":142.36,"value":93815.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units."}],"balance_after":6822,"source":{"system":"sec-edgar","filing":"0001232524-17-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000152/edgardoc.xml","form_type":"4"}},{"id":4235133,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2017-08-14T21:33:06.000Z","date":"2017-08-10","kind":"grant","acquired":true,"shares":1365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2018."}],"balance_after":7481,"source":{"system":"sec-edgar","filing":"0001232524-17-000152","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1232524/000123252417000152/edgardoc.xml","form_type":"4"}},{"id":4293867,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true}}],"security":"Right to Buy Restricted Stock Unit (RSU)","published_at":"2017-06-05T23:26:31.000Z","date":"2017-06-01","kind":"exercise","acquired":true,"shares":4286,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock."}],"balance_after":4286,"derivative":{"exercise_date":"2018-06-01","underlying":"Common Stock","underlying_shares":4286},"source":{"system":"sec-edgar","filing":"0001437749-17-010672","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000143774917010672/rdgdoc.xml","form_type":"4"}},{"id":4303636,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2017-05-26T23:05:21.000Z","date":"2017-05-25","kind":"exercise","acquired":false,"shares":5282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units were granted on May 25, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested on May 25, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested on May 25, 2017."}],"balance_after":0,"derivative":{"exercise_date":"2017-05-25","expiration_date":"2017-05-25","underlying":"Common Stock","underlying_shares":5282},"source":{"system":"sec-edgar","filing":"0001437749-17-010193","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000143774917010193/rdgdoc.xml","form_type":"4"}},{"id":4303635,"issuer":{"id":6447,"kind":"organization","name":"LIFECORE BIOMEDICAL, INC. \\DE\\"},"owners":[{"id":50273,"kind":"person","name":"Sohn Catherine A.","position":1,"cik":"0001555132","reported_name":"Sohn Catherine A.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-26T23:05:21.000Z","date":"2017-05-25","kind":"exercise","acquired":true,"shares":5282,"price":13.5,"value":71307.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis."}],"balance_after":19805,"source":{"system":"sec-edgar","filing":"0001437749-17-010193","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1005286/000143774917010193/rdgdoc.xml","form_type":"4"}}]}